RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis
Mar 2011 - 4 pages - $500
Cystic Fibrosis - Drug Pipeline Analysis and Market Forecasts to 2015
Dec 2009 - 46 pages - $2,000
Cystic Fibrosis – Pipeline Assessment and Market Forecasts to 2017
Aug 2010 - 49 pages - $2,000
Cystic Fibrosis Therapy Area Pipeline Report
Nov 2010 - 176 pages - $1,495
Cystic Fibrosis - Pipeline Review, Q1 2011
Feb 2011 - 84 pages - $500
Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015
Jan 2011 - 124 pages - $1,740
Cystic Fibrosis - Pipeline Review, H2 2011
Sep 2011 - 174 pages - $500
Respiratory Disorders Therapeutics Market to 2017 - Novel Pipeline Molecules such as VX-770 and pirfenidone May Offset Negative Effect of Patent Expiries
Sep 2011 - 171 pages - $3,500
R&D Trends: Cystic Fibrosis – New drugs tackle both cause and effect
Oct 2011 - 68 pages - $3,800
Delivering Opportunities in the Inhalable Drugs Market
Feb 2010 - 155 pages - $3,835
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Oral solid del
Therapeutic target
Respiratory del
Cystic fibrosis del

Browse By

Industry sector
Cachet
Capsule
Chewing gum
Granule/Powder
Lozenge
Other
Sustained Release
Sweet/Candy/Bonbon
Tablet
Year
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us